v3.25.2
Accounting policies - Effect of restatements (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 29, 2025
Mar. 30, 2024
Dec. 28, 2024
Dec. 30, 2023
Balance sheet:        
Cash and cash equivalents $ 27 $ 71 $ 47  
Inventories 389 333 367  
Total current assets 670 670 640  
Total assets 2,034 1,894 1,983  
Notes payable 69 3 51  
Other current liabilities 98 92 97  
Total current liabilities 840 792 851  
Retained earnings 33 23 27  
Total equity 341 320 328 $ 302
Total liabilities and equity 2,034 1,894 1,983  
Statement of comprehensive income:        
Cost of goods sold 470 502    
Operating profit 24 48    
Income before income taxes 26 46    
Income taxes (benefit) 5 12    
Net income 21 34    
Comprehensive income $ 18 $ 31    
Basic earnings (in dollars per share) $ 0.25 $ 0.40    
Diluted earnings (in dollars per share) $ 0.24 $ 0.39    
Operating activities        
Net income $ 21 $ 34    
Changes in operating assets and liabilities:        
Inventories (22) 14    
Income taxes payable 3 5    
Accounts payable 22 (5)    
Net cash provided by (used in) operating activities (9) 10    
Financing activities        
Net increase (reduction) of notes payable, with maturities less than or equal to 90 days   (2)    
Net cash provided by (used in) financing activities 49 (18)    
Increase (decrease) in cash and cash equivalents (20) (17)    
Cash and cash equivalents at end of period 27 71 47 $ 88
As Reported        
Balance sheet:        
Cash and cash equivalents   70    
Inventories 371 328    
Total current assets 652 664    
Total assets 2,016 1,888    
Notes payable   2    
Other current liabilities 94 90    
Total current liabilities 836 789    
Retained earnings 19 20    
Total equity 327 317    
Total liabilities and equity 2,016 1,888    
Statement of comprehensive income:        
Cost of goods sold 474 504    
Operating profit 20 46    
Income before income taxes 22 44    
Income taxes (benefit) 4 11    
Net income 18 33    
Comprehensive income $ 15 $ 30    
Basic earnings (in dollars per share) $ 0.20 $ 0.38    
Diluted earnings (in dollars per share) $ 0.20 $ 0.37    
Operating activities        
Net income $ 18 $ 33    
Changes in operating assets and liabilities:        
Inventories (18) 16    
Income taxes payable 2 4    
Accounts payable 29      
Net cash provided by (used in) operating activities (2) 10    
Financing activities        
Net increase (reduction) of notes payable, with maturities less than or equal to 90 days   (3)    
Net cash provided by (used in) financing activities   (19)    
Increase (decrease) in cash and cash equivalents (13) (18)    
Cash and cash equivalents at end of period   70 40  
Adjustment        
Balance sheet:        
Cash and cash equivalents   1    
Inventories 18 5    
Total current assets 18 6    
Total assets 18 6    
Notes payable   1    
Other current liabilities 4 2    
Total current liabilities 4 3    
Retained earnings 14 3    
Total equity 14 3    
Total liabilities and equity 18 6    
Statement of comprehensive income:        
Cost of goods sold (4) (2)    
Operating profit 4 2    
Income before income taxes 4 2    
Income taxes (benefit) 1 1    
Net income 3 1    
Comprehensive income $ 3 $ 1    
Basic earnings (in dollars per share) $ 0.05 $ 0.02    
Diluted earnings (in dollars per share) $ 0.04 $ 0.02    
Operating activities        
Net income $ 3 $ 1    
Changes in operating assets and liabilities:        
Inventories (4) (2)    
Income taxes payable 1 1    
Accounts payable (7)      
Net cash provided by (used in) operating activities (7) 0    
Financing activities        
Net increase (reduction) of notes payable, with maturities less than or equal to 90 days   1    
Net cash provided by (used in) financing activities   1    
Increase (decrease) in cash and cash equivalents $ (7) 1    
Cash and cash equivalents at end of period   $ 1 $ 7